Topiramate Capsule, Extended Release
Pricing Report NDC 69680-179-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Topiramate (NDC 69680-179-30) is $5.59592 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Vitruvias Therapeutics, Inc., this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.59592
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$167.88
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
69680-179-30
Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2025, the NADAC wholesale price for (NDC ) has moved within a range of $5.59592 to $9.67392 per EA. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.5959 - $9.6739
Market Volatility
72.87% Variance
Latest Trend
1.21%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $5.59592 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $5.66437 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $6.26097 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $6.92003 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $7.86738 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $8.24681 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $8.43729 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 19, 2025 $8.50139 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 22, 2025 $8.43919 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Sep 17, 2025 $8.70376 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2025 $8.85769 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 23, 2025 $9.24146 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 09, 2025 $9.67392 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026